Cart
sales@molnova.com
JCP251
CAS No. 62252-26-0
JCP251( JCP-251 | JCP 251 )
Catalog No. M15354 CAS No. 62252-26-0
JCP251 is a selective small molecule inhibitor of S. aureus serine hydrolase FphB, effectively reduces infectivity in vivo.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 246 | Get Quote |
|
| 10MG | 352 | Get Quote |
|
| 25MG | 590 | Get Quote |
|
| 50MG | 839 | Get Quote |
|
| 100MG | 1143 | Get Quote |
|
| 500MG | 2277 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameJCP251
-
NoteResearch use only, not for human use.
-
Brief DescriptionJCP251 is a selective small molecule inhibitor of S. aureus serine hydrolase FphB, effectively reduces infectivity in vivo.
-
DescriptionJCP251 is a selective small molecule inhibitor of S. aureus serine hydrolase FphB, effectively reduces infectivity in vivo.
-
In Vitro——
-
In Vivo——
-
SynonymsJCP-251 | JCP 251
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number62252-26-0
-
Formula Weight225.628
-
Molecular FormulaC10H8ClNO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1OC(OC)=C(Cl)C2=C1C=C(N)C=C2
-
Chemical Name7-amino-4-chloro-3-methoxy-1H-isochromen-1-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lentz CS, et al. Nat Chem Biol. 2018 May 16. doi: 10.1038/s41589-018-0060-1.
molnova catalog
related products
-
Ombuin
Ombuin has anti-inflammatory activity, it inhibits some macrophage functions involved in the inflammatory process.
-
InhA-IN-4
InhA-IN-4 (TU14) is a potent inhibitor of Mycobacterium tuberculosis InhA (enoyl ACP reductase), with potential anticancer and antiproliferative activities for studying Mycobacterium tuberculosis infections.
-
Contezolid
Contezolid (MRX I) is an orally active oxazolidinone agent with antibacterial activity Gram-positive pathogens, including MRSA, penicillin-PRSP, PISP, and vancomycin-resistant enterococci (VRE) with MIC of 0.25-4 ug/mL.
